Heart valve disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18-80 years old; 2) thoracotomy patients with severe valvular disease, planned for mitral valve and/or aortic valve replacement/repair; 3) EF value of admitted cardiac ultrasound >35%; 4) Agree to participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Concurrent with other severe systemic diseases; 2) Patients requiring emergency surgery; 3) is participating in or has participated in other trials within the past 12 months; 4) Severe limb dysfunction or cognitive impairment, unable to cooperate with intervention; 5) Unstable vital signs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6 minutes walking test(6MWT);Diaphragm ultrasound;Lung function;Respiratory muscle strength;Inflammatory factor;Incidence of pulmonary complications after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of stay;Hospitalization expenses;Patient compliance;Readmission rate;The power of gripping;Improved Barthel index;Duke Activity State Index (DASI);Drainage tube removal time;Duration of ventilator use; | — |
Countries
China
Contacts
First Affiliated Hospital of Air Force MedicalUniversity (Xiiing Hospital)